Literature DB >> 28378174

Rapidly progressive IgA nephropathy.

Naho Kobayashi1, Masashi Nishida2, Michiko Aoyama3, Kentaro Yokoi3, Tomoyo Yahata1, Tatsujiro Oka1, Koichi Sakata1, Isao Shiraishi1, Toshiyuki Itoi1, Kenji Hamaoka1.   

Abstract

A 14-year-old boy presented with macroscopic hematuria and a rapid deterioration in renal function. Percutaneous renal biopsy demonstrated severe crescentic IgA nephropathy (IgAN) with extensive (88%) glomerular crescent formation. After started intravenous administration of high-dose pulse methylprednisolone, severe nausea and general malaise accompanied by a rapid increase in Blood Urea Nitrogen (BUN) and serum creatinine levels appeared, however, the renal function ameliorated rapidly and fully revovered by following oral administration of corticosteroid. The clinical presentation of our case seems to be very remarkable compared to previously reported cases of rapidly progressive IgAN.

Entities:  

Keywords:  Acute renal failure; Diffuse crescentic glomerulonephritis; IgA nephropathy; Rapidly progressive glomerulonephritis

Year:  2005        PMID: 28378174     DOI: 10.1007/BF02859270

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

1.  "Pulse" methylprednisolone therapy in the treatment of severe glomerulonephritis.

Authors:  B R Cole; J T Brocklebank; R A Kienstra; J M Kissane; A M Robson
Journal:  J Pediatr       Date:  1976-02       Impact factor: 4.406

2.  Does methylprednisolone pulse therapy deteriorate the course of rapidly progressive IgA nephropathy?

Authors:  N Itami; Y Akutsu; Y Kusunoki; H Tochimaru; Y Takekashi
Journal:  Am J Dis Child       Date:  1989-04

3.  Chronic mesangioproliferative IgA glomerulonephritis complicated by a rapidly progressive course in a 14-year-old boy. A case report.

Authors:  A Martini; U Magrini; M Scelsi; V Capelli; L Barberis
Journal:  Nephron       Date:  1981       Impact factor: 2.847

Review 4.  Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendations.

Authors:  K K Jindal
Journal:  Kidney Int Suppl       Date:  1999-06       Impact factor: 10.545

5.  Effects of the methylprednisolone pulse therapy on renal function.

Authors:  T Sakemi; M Yamaguchi; S Fujimi; Y Nagano; M Uchida
Journal:  Am J Nephrol       Date:  1991       Impact factor: 3.754

Review 6.  Treatment of glomerular diseases: ANCA-negative RPGN.

Authors:  W K Bolton
Journal:  Semin Nephrol       Date:  2000-05       Impact factor: 5.299

7.  Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis.

Authors:  W K Bolton; B C Sturgill
Journal:  Am J Nephrol       Date:  1989       Impact factor: 3.754

8.  [A case of rapidly progressive IgA nephropathy with transient hypocomplementemia at onset].

Authors:  Y Yamazaki; A Mori; Y Nomura; A Satoh; K I Park; H Kawakatsu; M Nishida
Journal:  Nihon Jinzo Gakkai Shi       Date:  1997-10

9.  Clinical course of immunoglobulin A nephropathy in children.

Authors:  N Yoshikawa; H Ito; S Yoshiara; C Nakahara; K Yoshiya; O Hasegawa; T Matsuo
Journal:  J Pediatr       Date:  1987-04       Impact factor: 4.406

10.  Rapidly progressive IgA nephropathy.

Authors:  T R Welch; A J McAdams; A Berry
Journal:  Am J Dis Child       Date:  1988-07
  10 in total
  1 in total

1.  Plasma exchange combined with immunosuppressive treatment in a child with rapidly progressive IgA nephropathy.

Authors:  Shuichiro Fujinaga; Yoshiyuki Ohtomo; Daisuke Umino; Hiroshi Mochizuki; Hitohiko Murakami; Toshiaki Shimizu; Yuichiro Yamashiro; Kazunari Kaneko
Journal:  Pediatr Nephrol       Date:  2007-02-07       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.